Mark W Tenforde

Best Publications

• Multisystem Inflammatory Syndrome in U.S. Children and Adolescents.

  Leora R. Feldstein;Leora R. Feldstein;Erica B. Rose;Erica B. Rose;Steven M. Horwitz;Jennifer P. Collins

  2867
  Citations

• Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19.

  Leora R. Feldstein;Leora R. Feldstein;Mark W. Tenforde;Kevin G. Friedman;Margaret Newhams

  811
  Citations

• Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study

  Unknown

  677
  Citations

• Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.

  Mark W Tenforde;Wesley H Self;Katherine Adams;Manjusha Gaglani

  657
  Citations

• Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.

  Wesley H. Self;Mark W. Tenforde;Jillian P. Rhoads;Manjusha Gaglani;Manjusha Gaglani

  425
  Citations

• Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome.

  Kerri L. Larovere;Becky J. Riggs;Tina Y. Poussaint;Cameron C. Young

  391
  Citations

• Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021.

  Mark W. Tenforde;Samantha M. Olson;Wesley H. Self;H. Keipp Talbot

  278
  Citations

• Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021.

  Mark W. Tenforde;Wesley H. Self;Eric A. Naioti;Adit A. Ginde

  223
  Citations

• Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network - 13 Academic Medical Centers, April-June 2020.

  Wesley H. Self;Mark W. Tenforde;William B. Stubblefield;Leora R. Feldstein

  223
  Citations

• Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated — VISION Network, 10 States, December 2021–June 2022

  Unknown

  208
  Citations

• Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022

  Unknown

  185
  Citations

• Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022

  Unknown

  183
  Citations

• Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study

  Unknown

  164
  Citations

• Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States.

  Mark W Tenforde;Manish M Patel;Adit A Ginde;David J Douin

  149
  Citations

• Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network-12 States, April-August 2020

  Wesley H Self;Mark W Tenforde;William B Stubblefield;Leora R Feldstein

  144
  Citations

• Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19–Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions — VISION Network, September 2022–April 2023

  Unknown

  138
  Citations

• Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance — VISION Network, 10 States, December 2021—August 2022

  Unknown

  130
  Citations

• Effect of antigenic drift on influenza vaccine effectiveness in the United States - 2019-2020.

  Mark W Tenforde;Rebecca J Garten Kondor;Jessie R Chung;Richard K Zimmerman

  122
  Citations

• Theoretical Framework for Retrospective Studies of the Effectiveness of SARS-CoV-2 Vaccines.

  Joseph A Lewnard;Manish M Patel;Nicholas P Jewell;Nicholas P Jewell;Jennifer R Verani

  120
  Citations

• Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for Patients With COVID-19-Nashville, Tennessee.

  William B Stubblefield;H Keipp Talbot;Leora R Feldstein;Mark W Tenforde

  115
  Citations